Press Releases
Report from Ambea’s annual shareholders’ meeting 11 May 2023
May 11, 2023
Today’s Annual General Meeting in Ambea AB (publ) voted to support all proposals from the board of directors and the nomination committee.

Ambea’s interim report January- March 2023
May 4, 2023
Stable organic growth and improved profitability.
Invitation: Presentation of Ambea’s first quarter 2023 results
April 20, 2023
Hosts: Mark Jensen, CEO and Benno Eliasson, CFO.
Notice of Annual General Meeting of Ambea AB (publ)
March 30, 2023
Ambea AB (publ), Reg.No. 556468-4354, with its registered office in Stockholm, gives notice of the Annual General Meeting to be held on Thursday 11 May 2023 at 10.00 a.m. at Vardaga Villa Solhem, Avestagatan 31, SE-163 53 Spånga, Sweden. Registration starts at 09.30 a.m.
Ambea publishes annual report with quality and sustainability report for 2022
March 28, 2023
Ambea’s annual report with quality and sustainability report for 2022 is published today on ambea.com and attach to this press release.
Notification regarding Ambea’s holding of own shares
February 23, 2023
After repurchases completed in accordance with a share repurchase program resolved on by the board of directors of Ambea AB (publ), the company’s holding of own shares on 22 February 2023 amounted to 4 757 388 shares, which corresponds to 5,03 percent of the total numbers of shares and votes in the company. The company’s holding of own shares thus exceeds five percent of the total numbers of shares and votes in the company.
Correction: Ambea year end report 2022
February 9, 2023
The correction refers to missing the word adjusted in the bullet points four in the summary of the fourth quarter (October – December) and full year (January – December) 2022. The correction only applies to the English version.Corrected press release and year-end report follows in its entirety.

Ambea’s year-end report 2022
February 9, 2023
Strong organic growth continued in the fourth quarter, and our Swedish divisions, Nytida and Vardaga, showed stable underlying earnings, while the strategic shift in Klara generated results.
Invitation: Presentation of Ambea’s fourth quarter 2022 results
January 26, 2023
Hosts: Mark Jensen, CEO and Benno Eliasson, CFO.

Ambea’s interim report July – September 2022
November 3, 2022
A return to strong organic growth in the third quarter and promising performance improvements for Stendi.
Ambea resolves on repurchase of own shares
November 2, 2022
The board of directors in Ambea AB (publ) has resolved to repurchase a maximum of 5,000,000 own shares on Nasdaq Stockholm during the period until the time of the company’s Annual General Meeting 2023. The resolution is made by virtue of the authorisation from the Annual General Meeting 2022 to repurchase own shares.
Ambea’s Nomination Committee appointed for the Annual General Meeting 2023
October 21, 2022
The Nomination Committee ahead of the 2023 consists of:
Invitation: Presentation of Ambea’s third quarter 2022 results
October 20, 2022
Hosts: Mark Jensen, CEO and Benno Eliasson, CFO.
Ambea divest staffing solutions for doctors
September 8, 2022
Klara, Ambeas staffing operation, divest staffing solutions for doctors to Hedera Group. The transition will be finalized today 8 of September.
Ambea’s interim report April- June 2022
August 18, 2022
Continued growth and stronger financial position.
Invitation: Presentation of Ambea’s second quarter 2022 results
August 4, 2022
Hosts: Mark Jensen, CEO and Benno Eliasson, CFO.
Ambea acquires two Danish social care companies
June 30, 2022
Altiden, a part of the Ambea group, acquires SK Reflekt and Huset Reflekt.
Report from Ambea’s annual shareholders’ meeting 12 May 2022
May 12, 2022
Today’s Annual General Meeting in Ambea AB (publ) voted to support all proposals from the board of directors and the nomination committee.

Ambea’s interim report January- March 2022
May 4, 2022
Strong quarter with favourable growth.
Nytida acquires family care company
May 2, 2022
Nytida, a part of the Ambea group, aquires Alternatus Familia AB.